Rifampicin-ofloxacin oral regimen for the treatment of mild to moderate diabetic foot osteomyelitis.
Senneville E, Yazdanpanah Y, Cazaubiel M, Cordonnier M, Valette M, Beltrand E, Khazarjian A, Maulin L, Alfandari S, Caillaux M, Dubreuil L, Mouton Y.
Senneville E, et al. Among authors: yazdanpanah y.
J Antimicrob Chemother. 2001 Dec;48(6):927-30. doi: 10.1093/jac/48.6.927.
J Antimicrob Chemother. 2001.
PMID: 11733482